LIMITED POWER OF ATTORNEY

      Know all by these presents, that the undersigned hereby authorizes Michael
C.  Carroll to execute for and on behalf of the undersigned, in the
undersigned's capacity as a Section 16 reporting person of Biolase, Inc., a
Delaware corporation (the "Company"), EDGAR Form ID (including amendments
thereto) and Authenticating Statements, Forms 3, 4 and 5, and any amendments
thereto, and cause such form(s) to be filed with the United States Securities
and Exchange Commission and The NASDAQ Stock Market.  The undersigned hereby
grants to such attorney-in-fact full power and authority to do and perform any
and every act and thing whatsoever requisite, necessary, or proper to be done in
exercise of any of the rights and powers herein granted, as fully to all intents
and purposes as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted.

      The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended or the rules
promulgated thereunder.

      This Limited Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 29th day of April, 2022.


By: /s/ Kenneth Yale
    ----------------------------
Print Name: Kenneth Yale